vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Forestar Group Inc. (FOR). Click either name above to swap in a different company.
Forestar Group Inc. is the larger business by last-quarter revenue ($273.0M vs $205.4M, roughly 1.3× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs 5.6%, a 2.6% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 9.0%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $-157.1M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -9.6%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Forestar Group Inc. is a residential lot development company based in Arlington, Texas. The company has operations in 51 markets in 21 states and delivered 11,518 residential lots during the twelve-month period ended December 31, 2020. The company is publicly traded on the New York Stock Exchange and in October 2017 became a majority-owned subsidiary of D.R. Horton, Inc., the largest homebuilder by volume in the United States since 2002. The company primarily acquires entitled real estate and...
COLL vs FOR — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $273.0M |
| Net Profit | $17.0M | $15.4M |
| Gross Margin | 62.5% | 20.1% |
| Operating Margin | 29.6% | 7.6% |
| Net Margin | 8.3% | 5.6% |
| Revenue YoY | 12.9% | 9.0% |
| Net Profit YoY | 35.3% | -6.7% |
| EPS (diluted) | $0.48 | $0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $273.0M | ||
| Q3 25 | $209.4M | $670.5M | ||
| Q2 25 | $188.0M | $390.5M | ||
| Q1 25 | $177.8M | $351.0M | ||
| Q4 24 | $181.9M | $250.4M | ||
| Q3 24 | $159.3M | $551.3M | ||
| Q2 24 | $145.3M | $318.4M | ||
| Q1 24 | $144.9M | $333.8M |
| Q4 25 | $17.0M | $15.4M | ||
| Q3 25 | $31.5M | $86.9M | ||
| Q2 25 | $12.0M | $32.9M | ||
| Q1 25 | $2.4M | $31.6M | ||
| Q4 24 | $12.5M | $16.5M | ||
| Q3 24 | $9.3M | $81.5M | ||
| Q2 24 | $19.6M | $38.7M | ||
| Q1 24 | $27.7M | $45.0M |
| Q4 25 | 62.5% | 20.1% | ||
| Q3 25 | 61.7% | 22.3% | ||
| Q2 25 | 57.7% | 20.4% | ||
| Q1 25 | 54.8% | 22.6% | ||
| Q4 24 | 54.0% | 22.0% | ||
| Q3 24 | 60.8% | 23.9% | ||
| Q2 24 | 62.5% | 22.5% | ||
| Q1 24 | 63.1% | 24.9% |
| Q4 25 | 29.6% | 7.6% | ||
| Q3 25 | 29.7% | 16.9% | ||
| Q2 25 | 18.7% | 11.2% | ||
| Q1 25 | 12.2% | 11.6% | ||
| Q4 24 | 20.9% | 8.7% | ||
| Q3 24 | 21.9% | 19.7% | ||
| Q2 24 | 32.7% | 16.2% | ||
| Q1 24 | 34.1% | 17.6% |
| Q4 25 | 8.3% | 5.6% | ||
| Q3 25 | 15.0% | 13.0% | ||
| Q2 25 | 6.4% | 8.4% | ||
| Q1 25 | 1.4% | 9.0% | ||
| Q4 24 | 6.9% | 6.6% | ||
| Q3 24 | 5.9% | 14.8% | ||
| Q2 24 | 13.5% | 12.2% | ||
| Q1 24 | 19.1% | 13.5% |
| Q4 25 | $0.48 | $0.30 | ||
| Q3 25 | $0.84 | $1.70 | ||
| Q2 25 | $0.34 | $0.65 | ||
| Q1 25 | $0.07 | $0.62 | ||
| Q4 24 | $0.36 | $0.32 | ||
| Q3 24 | $0.27 | $1.59 | ||
| Q2 24 | $0.52 | $0.76 | ||
| Q1 24 | $0.71 | $0.89 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $211.7M |
| Total DebtLower is stronger | — | $793.2M |
| Stockholders' EquityBook value | $301.7M | $1.8B |
| Total Assets | $1.7B | $3.2B |
| Debt / EquityLower = less leverage | — | 0.44× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $211.7M | ||
| Q3 25 | $285.9M | $379.2M | ||
| Q2 25 | $222.2M | $189.2M | ||
| Q1 25 | $197.8M | $174.3M | ||
| Q4 24 | $162.8M | $132.0M | ||
| Q3 24 | $120.0M | $481.2M | ||
| Q2 24 | $271.6M | $359.2M | ||
| Q1 24 | $318.0M | $416.2M |
| Q4 25 | — | $793.2M | ||
| Q3 25 | — | $802.7M | ||
| Q2 25 | — | $872.8M | ||
| Q1 25 | — | $872.5M | ||
| Q4 24 | — | $806.8M | ||
| Q3 24 | — | $706.4M | ||
| Q2 24 | — | $706.1M | ||
| Q1 24 | — | $705.7M |
| Q4 25 | $301.7M | $1.8B | ||
| Q3 25 | $274.8M | $1.8B | ||
| Q2 25 | $232.2M | $1.7B | ||
| Q1 25 | $234.4M | $1.6B | ||
| Q4 24 | $228.8M | $1.6B | ||
| Q3 24 | $234.3M | $1.6B | ||
| Q2 24 | $216.6M | $1.5B | ||
| Q1 24 | $222.2M | $1.5B |
| Q4 25 | $1.7B | $3.2B | ||
| Q3 25 | $1.6B | $3.1B | ||
| Q2 25 | $1.6B | $3.1B | ||
| Q1 25 | $1.6B | $3.0B | ||
| Q4 24 | $1.7B | $3.0B | ||
| Q3 24 | $1.6B | $2.8B | ||
| Q2 24 | $1.1B | $2.7B | ||
| Q1 24 | $1.1B | $2.6B |
| Q4 25 | — | 0.44× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.52× | ||
| Q1 25 | — | 0.53× | ||
| Q4 24 | — | 0.50× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.47× | ||
| Q1 24 | — | 0.48× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $-157.0M |
| Free Cash FlowOCF − Capex | $122.4M | $-157.1M |
| FCF MarginFCF / Revenue | 59.6% | -57.5% |
| Capex IntensityCapex / Revenue | 0.3% | 0.0% |
| Cash ConversionOCF / Net Profit | 7.25× | -10.19× |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $93.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $-157.0M | ||
| Q3 25 | $78.4M | $256.3M | ||
| Q2 25 | $72.4M | $15.8M | ||
| Q1 25 | $55.4M | $-19.8M | ||
| Q4 24 | $84.6M | $-450.0M | ||
| Q3 24 | $-9.0M | $119.2M | ||
| Q2 24 | $67.4M | $-61.7M | ||
| Q1 24 | $61.9M | $-59.2M |
| Q4 25 | $122.4M | $-157.1M | ||
| Q3 25 | $78.3M | $255.6M | ||
| Q2 25 | $72.4M | $15.0M | ||
| Q1 25 | $54.6M | $-20.5M | ||
| Q4 24 | $84.1M | — | ||
| Q3 24 | $-9.2M | $118.4M | ||
| Q2 24 | $67.1M | $-62.3M | ||
| Q1 24 | $61.4M | $-59.8M |
| Q4 25 | 59.6% | -57.5% | ||
| Q3 25 | 37.4% | 38.1% | ||
| Q2 25 | 38.5% | 3.8% | ||
| Q1 25 | 30.7% | -5.8% | ||
| Q4 24 | 46.2% | — | ||
| Q3 24 | -5.8% | 21.5% | ||
| Q2 24 | 46.2% | -19.6% | ||
| Q1 24 | 42.3% | -17.9% |
| Q4 25 | 0.3% | 0.0% | ||
| Q3 25 | 0.1% | 0.1% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.4% | 0.2% | ||
| Q4 24 | 0.3% | 0.0% | ||
| Q3 24 | 0.2% | 0.1% | ||
| Q2 24 | 0.2% | 0.2% | ||
| Q1 24 | 0.4% | 0.2% |
| Q4 25 | 7.25× | -10.19× | ||
| Q3 25 | 2.49× | 2.95× | ||
| Q2 25 | 6.05× | 0.48× | ||
| Q1 25 | 22.92× | -0.63× | ||
| Q4 24 | 6.75× | -27.27× | ||
| Q3 24 | -0.96× | 1.46× | ||
| Q2 24 | 3.44× | -1.59× | ||
| Q1 24 | 2.23× | -1.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
